These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15740719)

  • 1. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.
    Gimpl G; Postina R; Fahrenholz F; Reinheimer T
    Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor.
    Postina R; Kojro E; Fahrenholz F
    J Biol Chem; 1996 Dec; 271(49):31593-601. PubMed ID: 8940177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells.
    Tahara A; Tsukada J; Tomura Y; Wada Ki; Kusayama T; Ishii N; Yatsu T; Uchida W; Tanaka A
    Br J Pharmacol; 2000 Jan; 129(1):131-9. PubMed ID: 10694212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional architecture of vasopressin/oxytocin receptors.
    Hibert M; Hoflack J; Trumpp-Kallmeyer S; Mouillac B; Chini B; Mahé E; Cotte N; Jard S; Manning M; Barberis C
    J Recept Signal Transduct Res; 1999; 19(1-4):589-96. PubMed ID: 10071787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of the oxytocin receptor/bioligand interactions.
    Politowska E; Czaplewski C; Ciarkowski J
    Acta Biochim Pol; 1999; 46(3):581-90. PubMed ID: 10698266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modelling of the vasopressin V2 receptor/antagonist interactions.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    Acta Biochim Pol; 1998; 45(1):19-26. PubMed ID: 9701492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
    Conklin DJ; Smith MP; Olson KR
    Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of vasopressin and oxytocin binding sites in the brain and upper spinal cord of the common marmoset.
    Schorscher-Petcu A; Dupré A; Tribollet E
    Neurosci Lett; 2009 Sep; 461(3):217-22. PubMed ID: 19539696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
    Ammar A; Roseau S; Butlen D
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics of the interaction between oxytocin and its myometrial receptor in sheep: a stepwise binding mechanism.
    Pliska V; Folkers G; Spiwok V
    Biochem Pharmacol; 2014 Sep; 91(1):119-27. PubMed ID: 25010721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.